Guffanti et al (2009) identified MALAT1 as an abundantly expressed lncRNA in breast tumours. Rare mutations were recently described in luminal breast cancer (Ellis et al, 2012). Clinical prognostic value of MALAT1 dysregulation in breast cancer is little known at this time (Xu et al, 2015). The gene discussed is MALAT1; the disease is breast cancer.